New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...

Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in ...

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic ...

The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the University of ...

Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients ...

Pancreatic cancer has the worst survival rates among all solid tumor types, and its incidence is increasing. Hypoxic conditions that arise from an imbalance between increased oxygen consumption and an ...

Revolution Medicines' promising KRAS inhibitors show potential in pancreatic cancer. See why we recommend a hold rating on ...

LUND, SE / ACCESS Newswire / January 29, 2025 / Alligator Bioscience (STO:ATORX) Publication validates encouraging clinical ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

Press Release ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data ...